302 related articles for article (PubMed ID: 29848769)
1. Venous thromboembolism in patients with cancer: design and rationale of a multicentre, prospective registry (Cancer-VTE Registry).
Ohashi Y; Ikeda M; Kunitoh H; Sasako M; Okusaka T; Mukai H; Fujiwara K; Nakamura M; Kimura T; Ibusuki K; Sakon M
BMJ Open; 2018 May; 8(5):e018910. PubMed ID: 29848769
[TBL] [Abstract][Full Text] [Related]
2. Design and rationale for the Japanese Registry of Rivaroxaban Effectiveness & Safety for the Prevention of Recurrence in Patients with Deep Vein Thrombosis and Pulmonary Embolism (J'xactly) study.
Okumura Y; Fukuda I; Nakamura M; Yamada N; Takayama M; Maeda H; Yamashita T; Ikeda T; Mo M; Yamazaki T; Hirayama A;
BMJ Open; 2018 Jun; 8(6):e020286. PubMed ID: 29934383
[TBL] [Abstract][Full Text] [Related]
3. One-year incidence of venous thromboembolism, bleeding, and death in patients with solid tumors newly initiating cancer treatment: Results from the Cancer-VTE Registry.
Ohashi Y; Ikeda M; Kunitoh H; Sasako M; Okusaka T; Mukai H; Fujiwara K; Nakamura M; Oba MS; Kimura T; Ibusuki K; Takita A; Sakon M
Thromb Res; 2022 May; 213():203-213. PubMed ID: 35282898
[TBL] [Abstract][Full Text] [Related]
4. Venous thromboembolism in cancer patients: report of baseline data from the multicentre, prospective Cancer-VTE Registry.
Ohashi Y; Ikeda M; Kunitoh H; Sasako M; Okusaka T; Mukai H; Fujiwara K; Nakamura M; Oba MS; Kimura T; Ibusuki K; Sakon M
Jpn J Clin Oncol; 2020 Oct; 50(11):1246-1253. PubMed ID: 32715307
[TBL] [Abstract][Full Text] [Related]
5. Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry stomach cancer subcohort.
Yoshikawa T; Sano T; Terashima M; Yamaguchi K; Bando E; Kawabata R; Yabusaki H; Shinohara H; Oba MS; Kimura T; Takita A; Sasako M
Gastric Cancer; 2023 Jul; 26(4):493-503. PubMed ID: 37004667
[TBL] [Abstract][Full Text] [Related]
6. Venous thromboembolism in Japanese patients with breast cancer: subgroup analysis of the Cancer-VTE Registry.
Ohsumi S; Watanabe K; Kondo N; Kosaka Y; Ishikawa T; Kitahara M; Kubo S; Oba MS; Kimura T; Takita A; Mukai H
Breast Cancer; 2023 Jul; 30(4):607-616. PubMed ID: 37069366
[TBL] [Abstract][Full Text] [Related]
7. Global Anticoagulant Registry in the Field - Venous Thromboembolism (GARFIELD-VTE). Rationale and design.
Weitz JI; Haas S; Ageno W; Angchaisuksiri P; Bounameaux H; Nielsen JD; Goldhaber SZ; Goto S; Kayani G; Mantovani L; Prandoni P; Schellong S; Turpie AG; Kakkar AK
Thromb Haemost; 2016 Nov; 116(6):1172-1179. PubMed ID: 27656711
[TBL] [Abstract][Full Text] [Related]
8. Incidence and risk factors for venous thromboembolism, bleeding, and death in colorectal cancer (Cancer-VTE Registry).
Ikeda M; Uetake H; Yoshino T; Hata T; Oba MS; Takita A; Kimura T
Cancer Sci; 2022 Nov; 113(11):3901-3911. PubMed ID: 35947508
[TBL] [Abstract][Full Text] [Related]
9. Rationale and design of three observational, prospective cohort studies including biobanking to evaluate and improve diagnostics, management strategies and risk stratification in venous thromboembolism: the VTEval Project.
Frank B; Ariza L; Lamparter H; Grossmann V; Prochaska JH; Ullmann A; Kindler F; Weisser G; Walter U; Lackner KJ; Espinola-Klein C; Münzel T; Konstantinides SV; Wild PS;
BMJ Open; 2015 Jul; 5(7):e008157. PubMed ID: 26133379
[TBL] [Abstract][Full Text] [Related]
10. Analysis of noncatheter-associated upper extremity deep venous thrombosis from the RIETE registry.
Newton DH; Monreal Bosch M; Amendola M; Wolfe L; Perez Ductor C; Lecumberri R; Levy MM;
J Vasc Surg Venous Lymphat Disord; 2017 Jan; 5(1):18-24.e1. PubMed ID: 27987605
[TBL] [Abstract][Full Text] [Related]
11. Recurrence of venous thromboembolism in patients with recent gestational deep vein thrombosis or pulmonary embolism: Findings from the RIETE Registry.
Barillari G; Londero AP; Brenner B; Nauffal D; Muñoz-Torrero JF; Del Molino F; Moustafa F; Madridano O; Martín-Martos F; Monreal M;
Eur J Intern Med; 2016 Jul; 32():53-9. PubMed ID: 26972931
[TBL] [Abstract][Full Text] [Related]
12. Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry pancreatic cancer subcohort.
Okusaka T; Saiura A; Shimada K; Ikeda M; Ioka T; Kimura T; Hosokawa J; Takita A; Oba MS
J Gastroenterol; 2023 Dec; 58(12):1261-1271. PubMed ID: 37676492
[TBL] [Abstract][Full Text] [Related]
13. Survival effects of inferior vena cava filter in patients with acute symptomatic venous thromboembolism and a significant bleeding risk.
Muriel A; Jiménez D; Aujesky D; Bertoletti L; Decousus H; Laporte S; Mismetti P; Muñoz FJ; Yusen R; Monreal M;
J Am Coll Cardiol; 2014 Apr; 63(16):1675-83. PubMed ID: 24576432
[TBL] [Abstract][Full Text] [Related]
14. Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters.
Schoot RA; Kremer LC; van de Wetering MD; van Ommen CH
Cochrane Database Syst Rev; 2013 Sep; (9):CD009160. PubMed ID: 24026801
[TBL] [Abstract][Full Text] [Related]
15. Venous thromboembolism in radiation therapy cancer patients: Findings from the RIETE registry.
Guy JB; Bertoletti L; Magné N; Rancoule C; Mahé I; Font C; Sanz O; Martín-Antorán JM; Pace F; Vela JR; Monreal M;
Crit Rev Oncol Hematol; 2017 May; 113():83-89. PubMed ID: 28427527
[TBL] [Abstract][Full Text] [Related]
16. Cancer-Associated Venous Thromboembolism in the Real World - From the COMMAND VTE Registry.
Sakamoto J; Yamashita Y; Morimoto T; Amano H; Takase T; Hiramori S; Kim K; Oi M; Akao M; Kobayashi Y; Toyofuku M; Izumi T; Tada T; Chen PM; Murata K; Tsuyuki Y; Saga S; Nishimoto Y; Sasa T; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Yoshikawa Y; Shiomi H; Kato T; Makiyama T; Ono K; Tamura T; Nakagawa Y; Kimura T;
Circ J; 2019 Oct; 83(11):2271-2281. PubMed ID: 31548438
[TBL] [Abstract][Full Text] [Related]
17. Comparing U.S. and Canadian treatment patterns on venous thromboembolism outcomes in the GARFIELD-VTE registry.
Chen AC; Rao AS; Oropallo A; Goldhaber SZ; Fluharty ME; Maheshwari U; Carrier M; Turpie AGG; Pieper K; Kayani G; Kakkar AK;
Thromb Res; 2023 Dec; 232():123-132. PubMed ID: 37976732
[TBL] [Abstract][Full Text] [Related]
18. Incidence, clinical characteristics and long-term prognosis of postoperative symptomatic venous thromboembolism: a retrospective cohort study.
Takeda C; Yamashita Y; Takeuchi M; Yonekura H; Dong L; Hamada M; Hirotsu A; Ono K; Kawakami K; Fukuda K; Morimoto T; Kimura T; Mizota T
BMJ Open; 2022 Feb; 12(2):e055090. PubMed ID: 35173005
[TBL] [Abstract][Full Text] [Related]
19. Rationale, design and methodology of TESEO study: a registry of thrombosis and neoplasia of SEOM (Spanish Society of Medical Oncology).
Muñoz-Langa J; Jimenez-Fonseca P; Carmona-Bayonas A; de Castro EM; Pérez-Segura P; Cánovas MS; Gomez D; Moran LO; de Tejada MBG; Seguí E; López GB; Adrián SG; Campos MC; Olmos VP; Portero BO; Moyano MS; Crespo JAS; Sánchez LT; Rebollo MA; Rivas PO; Altozano JP; Lescure ÁR; Muñoz-Martín A
Clin Transl Oncol; 2021 Apr; 23(4):799-811. PubMed ID: 32789772
[TBL] [Abstract][Full Text] [Related]
20. Rivaroxaban for Preventing Venous Thromboembolism in High-Risk Ambulatory Patients with Cancer: Rationale and Design of the CASSINI Trial. Rationale and Design of the CASSINI Trial.
Khorana AA; Vadhan-Raj S; Kuderer NM; Wun T; Liebman H; Soff G; Belani C; O'Reilly EM; McBane R; Eikelboom J; Damaraju CV; Beyers K; Dietrich F; Kakkar AK; Riess H; Peixoto RD; Lyman GH
Thromb Haemost; 2017 Nov; 117(11):2135-2145. PubMed ID: 28933799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
